The chemical class known as FIT1 Inhibitors comprises a diverse array of compounds that interact with various aspects of lipid metabolism and cellular energy regulation. This class is characterized by its capacity to influence the functioning of Fat Storage-Inducing Transmembrane Protein 1 (FIT1), a protein integral to the processes of lipid storage and metabolism within cells. These inhibitors, through their unique mechanisms of action, can modulate the activity of FIT1, which is pivotal in lipid droplet formation and the overall regulation of lipid homeostasis. By engaging with different stages and components of lipid metabolism, these compounds can affect the functionality of FIT1, thereby playing a role in the management of lipid levels within cells.
The actions of FIT1 inhibitors are diverse, reflecting the complexity of lipid metabolism pathways. Some members of this class target the initial stages of lipid synthesis and processing, influencing the way lipids are handled within the cell. This approach can alter the availability of lipids for storage, thereby impacting the activity of FIT1 in lipid droplet formation. Other compounds in this class focus on the later stages of lipid metabolism, including lipid breakdown and utilization. By modulating these processes, these inhibitors can affect the dynamics of lipid storage and release, indirectly influencing the function of FIT1. This multifaceted approach allows for the regulation of lipid levels within cells, crucial for maintaining cellular energy balance and overall metabolic health. In addition to their role in lipid metabolism, FIT1 inhibitors are also involved in the broader context of energy regulation within cells. By influencing how lipids are stored and utilized, these compounds can impact cellular energy states. This is particularly relevant in cells with high energy demands or in conditions where energy balance is disrupted. The ability of these inhibitors to interact with key metabolic pathways underscores their significance in the regulation of cellular homeostasis. Overall, the FIT1 inhibitors represent a significant class of compounds with the ability to modulate lipid metabolism and cellular energy regulation. Their diverse mechanisms of action, targeting different aspects of lipid metabolism, reflect the intricate nature of these biological processes. By influencing the activity of FIT1, these inhibitors play a crucial role in the management of lipid levels within cells, contributing to the regulation of metabolic health and energy balance.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lipase Inhibitor, THL | 96829-58-2 | sc-203108 | 50 mg | $52.00 | 7 | |
Orlistat, an inhibitor of gastrointestinal lipases, reduces fat absorption. This change in lipid processing could possibly inhibit FITM1 function. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone is a PPAR gamma agonist that influences lipid storage and adipogenesis, which could possibly impact FITM1 activity. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
As a PPAR gamma agonist, Rosiglitazone modulates lipid storage and adipocyte differentiation, and could possibly influence FITM1 function. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
Fenofibrate, a PPAR alpha agonist, modulates lipid metabolism, especially triglyceride levels, and could possibly affect FITM1. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $257.00 $505.00 | 9 | |
Atorvastatin lowers cholesterol synthesis, which could possibly influence FITM1 activity by altering lipid homeostasis. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Simvastatin reduces cholesterol synthesis and could possibly affect FITM1 similar to other statins. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $62.00 $124.00 | 1 | |
Nicotinic Acid, or niacin, influences lipid metabolism and could possibly affect pathways involving FITM1. | ||||||
Acipimox | 51037-30-0 | sc-203497 sc-203497A | 50 mg 100 mg | $79.00 $131.00 | ||
Acipimox, a niacin derivative, reduces serum free fatty acids and could possibly influence FITM1 activity through changes in lipid metabolism. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $92.00 | 1 | |
Berberine regulates lipid metabolism and could possibly affect FITM1 function. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol influences lipid metabolism and insulin sensitivity, and could possibly impact FITM1 activity. | ||||||